-Anthony D Kelleher Researcher Activity Profile

Research Author Detailed Information 

Anthony D Kelleher Publication Rate By Year

Anthony D Kelleher has published 2 paper(s) in 2003, 3 paper(s) in 2006, 7 paper(s) in 2007, for a total of 12 research publications in total.

Anthony D Ad Kelleher Author Information

LAST NAME: kelleher

FIRST NAME: Anthony D

INITIALS: ad

AFFILIATION:

Papers

Anthony D Kelleher's Publication Record

1. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Year Published: 2003
School of Mathematics, University of NSW, Sydney, Australia. j.murray@unsw.edu.au
2. A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1. Year Published: 2006
3. Greater CD4 T-cell gains after one year of antiretroviral therapy are associated with lower HIV-1 pol replication capacity. Year Published: 2006
Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California, San Francisco, California, USA.
4. Rapid reversion of sequence polymorphisms dominates early human immunodeficiency virus type 1 evolution. Year Published: 2006
Partners AIDS Research Center, MGH-East, CNY 6616, 149 13th Street, Charlestown, MA 02129, USA.
5. Upregulation of CTLA-4 by HIV-specific CD4(+) T cells correlates with disease progression and defines a reversible immune dysfunction. Year Published: 2007
[1] Partners AIDS Research Center, Massachusetts General Hospital and Division of AIDS, Harvard Medical School, Boston, Massachusetts 02115, USA. [2] These authors contributed equally to this work.
6. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
7. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. Year Published: 2007
From the aNational Centre in HIV Epidemiology and Clinical Research, Australia bSchool of Mathematics and Statistics, University of New South Wales, Sydney, Australia cMerck Research Laboratories, North Wales, Pennsylvania, USA.
8. Naive T cells are maintained by thymic output in early ages but by proliferation without phenotypic change after age twenty. Year Published: 2003
School of Mathematics, University of NSW, Sydney, Australia. j.murray@unsw.edu.au
9. Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
10. Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase. Year Published: 2007
National Centre in HIV Epidemiology and Clinical Research, Sydney, NSW 2052, Australia. J.Murray@unsw.edu.au
11. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. dkaufmann@partners.org
12. Upregulation of CTLA-4 by HIV-specific CD4+ T cells correlates with disease progression and defines a reversible immune dysfunction. Year Published: 2007
Partners AIDS Research Center, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. dkaufmann@partners.org